Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F E André

Showing results (1-10 of 59) with videos related to

Pageof 6
Sort By:
BMJ (Clinical Research Ed.)|October 9, 1993
Stability of vaccinesF E André
Vaccine|April 9, 1999
Development and clinical application of new polyvalent combined paediatric vaccinesF E André
The Journal of Infectious Diseases|March 1, 1995
Approaches to a vaccine against hepatitis A: development and manufacture of an inactivated vaccineF E André
Developments in Biologicals|January 5, 2002
Strengths and weaknesses of current polio vaccines--a view from industryF E André
Reviews of Infectious Diseases|May 1, 1984
Control of poliomyelitis by vaccination in BelgiumF E André
Vaccine|March 21, 2001
The future of vaccines, immunisation concepts and practiceF E André
Biologicals : Journal of the International Association of Biological Standardization|December 1, 1994
Development of combined vaccines: manufacturers' viewpointF E André
Developments in Biologicals|December 13, 2002
How the research-based industry approaches vaccine development and establishes prioritiesF E André
Current Topics in Microbiology and Immunology|September 23, 2006
Universal mass vaccination against hepatitis AF E André
Vaccine|March 1, 1990
Overview of a 5-year clinical experience with a yeast-derived hepatitis B vaccineF E André
Pageof 6

Showing results (1-10 of 59) with videos related to

Sort By:
Pageof 6
BMJ (Clinical Research Ed.)|October 9, 1993
Stability of vaccinesF E André
Vaccine|April 9, 1999
Development and clinical application of new polyvalent combined paediatric vaccinesF E André
The Journal of Infectious Diseases|March 1, 1995
Approaches to a vaccine against hepatitis A: development and manufacture of an inactivated vaccineF E André
Developments in Biologicals|January 5, 2002
Strengths and weaknesses of current polio vaccines--a view from industryF E André
Reviews of Infectious Diseases|May 1, 1984
Control of poliomyelitis by vaccination in BelgiumF E André
Vaccine|March 21, 2001
The future of vaccines, immunisation concepts and practiceF E André
Biologicals : Journal of the International Association of Biological Standardization|December 1, 1994
Development of combined vaccines: manufacturers' viewpointF E André
Developments in Biologicals|December 13, 2002
How the research-based industry approaches vaccine development and establishes prioritiesF E André
Current Topics in Microbiology and Immunology|September 23, 2006
Universal mass vaccination against hepatitis AF E André
Vaccine|March 1, 1990
Overview of a 5-year clinical experience with a yeast-derived hepatitis B vaccineF E André
Pageof 6